Keywords
How to Cite
Abstract
Аутовоспалительные синдромы (АВС) представляют собой разнородную группу генетически детерминированных заболеваний, в основе которых лежит нарушение регуляции механизмов воспаления. Несмотря на внешнее отличие у «традиционных» первичных иммунодефицитных состояний (ПИДС) и АВС прослеживается много параллелей: гиподиагностика, мультисистемность поражения, осложнения, вызванные хроническим воспалением, возможность консервативной терапии с использованием ингибиторов цитокинов и кардинального излечения с помощью трансплантации стволовых клеток и генной терапии. Описано более 25 различных АВС, их общими проявлениями являются эпизоды лихорадки, сопровождающиеся лабораторной воспалительной активностью, полиморфная сыпь, лимфопролиферативный синдром и поражение различных органов. В диагностике «традиционных» ПИДС и АВС важная роль отводится генетическому анализу.
References
Casanova JL, Fieschi C, Zhang SY, Abel L. Revisiting primary immunodeficiencies. J Intern Med. 2008 Aug;264(2):115–27. doi: 10.1111/j.1365-2796.2008.01971.x. Epub 2008 Jun 9.
Martinon F, Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007 Jan;14(1):10–22. Epub 2006 Sep 15.
Savic S, Dickie LJ, Wittmann M, McDermott MF. Autoinflammatory syndromes and cellular responses to stress: pathophysiology, diagnosis and new treatment perspectives. Best Pract Res Clin Rheumatol. 2012 Aug;26(4):505–33. doi: 10.1016/j.berh.2012.07.009.
Щербина АЮ, Пашанов ЕД, редакторы. Иммунология детского возраста. Практическое руководство по детским болезням. Москва: Медпрактика-М; 2006. 432 c. [Shcherbina AYu, Pashanov ED, editors. Immunologiya detskogo vozrasta. Prakticheskoe rukovodstvo po detskim boleznyam [Immunology in children. A practical guide to childhood illnesses]. Moscow: Medpraktika-M; 2006. 432 p.]
Al-Herz W, Bousfiha A, Casanova JL, et al. Primary immunodeficiency diseases: an update on the classification from the International Union of Immunological Societies Expert committee for primary immunodeficiencies. Front Immunol. 2014 Apr 22;5:162. doi: 10.3389/fimmu.2014. 00162. eCollection 2014.
Caso F, Rigante D, Vitale A, et al. Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. Int J Rheumatol. 2013;2013:513782. doi: 10.1155/2013/ 513782. Epub 2013 Oct 24.
Барабанова ОВ, Коноплeва ЕА, Продеус АП, Щербина АЮ. Периодические синдромы. Трудный пациент. 2007;(2):46–52. [Barabanova OV, Konopleva EA, Prodeus AP, Shcherbina AYu. Periodic syndromes. Trudnyi patsient. 2007;(2):46–52. (In Russ.)].
Dinarello CA. Bloking IL-1 in systemic inflammation. J Exp Med. 2005 May 2;201(9):1355–9.
Giannelou A, Zhou Q, Kastner DL. When less is more: primary immunodeficiency with an autoinflammatory kick. Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):491–500. doi: 10.1097/ACI.0000000000000117.
Stjernberg-Salmela S, Kivisaari A, Puolakkainen P, et al. Intra-abdominal abscess in a patient with tumor necrosis factor receptor-associated periodic syndrome. J Intern Med. 2006 Feb;259(2):209–13.
Sornsakrin M, Wenner K, Ganschow R. B-cell cytopenia in two brothers with hyperIgD and periodic fever syndrome. Eur J Pediatr. 2009 Jul;168(7):825–31. doi: 10.1007/s00431-008-0843-6. Epub 2008 Oct 7.
Boisson B, Laplantine E, Prando C, et al. Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency. Nat Immunol. 2012 Dec;13(12):1178–86. doi: 10.1038/ni.2457. Epub 2012 Oct 28.
Galloway JB, Hyrich KL, Mercer LK, et al. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis easpecially in the first 6 months of treatment: updated results from the British Register with special emphasis on risks in the elderly. Rheumatology (Oxford). 2011 Jan;50(1):124–31. doi: 10.1093/rheumatology/keq242. Epub 2010 Jul 31.
Galloway JB, Hyrich KL, Mercer LK, et al. The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology (Oxford). 2011 Jul;50(7):1341–2. doi: 10.1093/rheumatology/ker146. Epub 2011 Apr 12.
Ida H, Kawasaki E, Miyashita T, et al. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus. Rheumatology (Oxford). 2004 Oct;43(10):1292–9. Epub 2004 Jul 27.
Oktendi C, Celik S. High frequency of inherited variants of the MEFV gene in patients with hematological neoplasms: a genetic susceptibility? Int J Hematol. 2012 Apr;95(4):380–5. doi: 10.1007/s12185-012- 1061-6. Epub 2012 Mar 28.
Holland SM. Chronic granulomatous disease. Hematol Oncol Clin North Am. 2013 Feb;27(1):89–99, viii. doi: 10.1016/j.hoc. 2012.11.002. Epub 2012 Nov 22.
Щербина АЮ, Косачева ТГ, Румянцев АГ. Первичные иммунодефицитные состояния: вопросы диагностики и лечения. Вопросы гематологии/онкологии и иммунологии в педиатрии. 2010;9(2):23–31. [Shcherbina AYu, Kosacheva TG, Rumyantsev AG. Primary immunodeficiency states: the questions of diagnostics and treatment. Voprosy gematologii/onkologii i immunologii v pediatrii. 2010;9(2):23–31. (In Russ.).]
Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D, et al. Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann Allergy Asthma Immunol. 2006 Aug;97(2):257–61.
Rieber N, Hector A, Kuijpers T, Roos D. Current concept of hyperinflammation in chronic granulomatous disease. Clin Dev Immunol. 2012;2012/252460. doi: 10.1155/2012/252460. Epub 2012 Aug 27.
Garg AD, Kaczmarek A, Krysko O, et al. ER stress-induced inflammation: does it aidor impede disease progression? Trends Mol Med. 2012 Oct;18(10):589–98. doi: 10.1016/j.molmed.2012.06.010. Epub 2012 Aug 8.
Meissner F, Seger RA, Moshous D, et al. Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease. Blood. 2010 Sep 2;116(9):1570–3. doi: 10.1182/blood-2010-01-264218. Epub 2010 May 21.
Xia J, Link DC. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol. 2008 Jan;15(1):1–7.
Conti P, Panara MR, Fridas S, et al. Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor agonist for interleukin-1 (hrIL-1ra). Cell Immunol. 1993 Apr 1;147(2):446–57.
van der Burg M, Genery AR. The expanding clinical and immunological spectrum of severe combined immunodeficiency. Eur J Pediatr. 2011 May;170(5):561–71. doi: 10.1007/s00431-011-1452-3. Epub 2011 Apr 9.
Sullivan KE. Chromosome 22q11.2 Deletion Syndrome: DiGeorge Syndrome/Velocardiofacial Syndrome. Immunol Allergy Clin North Am. 2008 May;28(2):353–66. doi: 10.1016/j.iac.2008.01.003.
Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood. 2008 Jan 1;111(1):439–45. Epub 2007 Sep 27.
Aksentijevich I, Putman D, Remmers EF, et al. The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum. 2007 Apr;56(4):1273–85.
Sauer AV, Di Lorenzo B, Carriglio N, Aiuti A. Progress in gene therapy for primary immunodeficiencies using lentiviral vectors. Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):527–34. doi: 10.1097/ACI.0000000000000114.
This work is licensed under a Creative Commons Attribution 4.0 International License.